
Arrow AI by Custom Social
OperatingCustom Social Inc.
Technology · Berkeley, DE · Founded 2019
Mission is to make digital advertising work for everyone
Financials
FY2019–FY2021 · from SEC filings · hover any figure for its sourceFigures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Post-money = pre-money + amount raised · caps markedA dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
Fundraising history
Team
6 people
As a serial entrepreneur and investor Pablo has built brands in the eCommerce and direct to consumer verticals in LATAM and globally. Pablo is also an investor in the bio-sciences, health technology, and software sectors. His company, MDR, based in Mexico City, operates in 30 countries and competes with multinational companies in the Pharmaceutical and Housewares categories. Pablo is committed to a world where innovation solves real business problems for small and medium businesses, solopreneurs, and believes that when small businesses win, we all win.

CEO and entrepreneur focused on building and delivering real solutions for businesses with a radical focus on value and growth online. The ability to build your business on the web is more important than ever and the technologies that support that growth need to meet the business owner at the intersection of their everyday lives - easy to use, empowered with AI, automated, mobile, and at your fingertips. This is what we do.

Over the past 30+ years in my career, I have been able to constantly learn new approaches and ways to solve problems using software. I have worked with some of the best minds in the industry where we brought the first Search Engine to the Internet (Infoseek, acquired by Disney) which brought information to everyone around the globe. I also had the pleasure of leading engineering at Frame Technology (acquired by Adobe) where we brought long document processing to all size computers. When the iPhone launched I worked with many companies and brands to bring advertising to mobile devices including Honda, Ford, Starbucks, CNBC, Toyota, McDonald's, LG, Unilever, Kraft, Disney, Time, AOL, and many, many more.

I create things that are designed to be used and enjoyed. Not just admired but interacted with. That demonstrate knowledge and feel personal. Because this is what makes design memorable. During my almost 20 year career, I’ve been lucky to work with some of the world’s most admired brands — companies like Alaska Airlines, Lululemon, All Recipes (Appy Award Winner ’14), GAP, Madison Square Garden, Target (Webby Award Winner ’15 and ’16), TOMS, HBO, Marvel, TED, and CNN. In recent years I’ve helped startups including Lottery.com, Spoon Rocket, Healthiest, Trizic, and Prevail design successful products and raise millions in funding.

Marty Glick is in his eighth season with the Golden State Warriors, his sixth as special advisor to ownership. In this capacity, Glick is primarily responsible for advising ownership on major strategic issues including the financing of Chase Center, the team’s state-of-the-art sports and entertainment center slated to open in the fall of 2019 in San Francisco and other major strategic initiatives. He is also a board member for the Warriors Community Foundation Prior to assuming his current role in the summer of 2013, Glick served two seasons as chief financial officer for the Warriors, overseeing all financial strategy, planning and accounting for the organization. He is also a minority owner. A highly-regarded former biotech executive whose affiliations have a history of innovative success, Glick has accumulated a wealth of experience as a prominent financial figure for several large biotech businesses during his career. He spent more than a decade (1987-1997) at Genentech of South San Francisco, where he most recently served as vice president of finance. He also served as executive vice president and chief financial officer of Theravance, a Bay Area-based drug discovery company, for seven years (1998-2005) and was a co-founder and board member of Eyetech Pharmaceuticals. Additionally, Glick was co-founder and chairman of the board of PEAK Surgical – an innovative private medical device company – and his résumé also includes a seven-plus year stint as the chair of the Biotech Tax and Finance Committee. A native of Chicago, Glick earned his MBA in Finance at Kellogg School of Management at Northwestern University, his Bachelor of Science in Business Administration (BSBA) in Accounting at Creighton University and is also a CPA and Chartered Accountant (Ontario, Canada).
Names and titles as disclosed on StartEngine, SEC Form C. Bios and photos come from the platform campaign page and may be out of date.
Reg CF annual-report compliance
Filed 1 of 5 annual reports (FY2021–FY2025)
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.
